Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis

scientific article published on 14 November 2018

Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1155/2018/2318386
P932PMC publication ID6261241
P698PubMed publication ID30538782

P50authorYeong Wook SongQ59822090
You-Jung HaQ60327690
Eun Ha KangQ88942838
Yun Jong LeeQ89612254
P2093author name stringDong Woo Han
Sang Wan Chung
Ji Hyoun Kim
P2860cites workBiology of RANK, RANKL, and osteoprotegerinQ21195419
Suppression of bone formation by osteoclastic expression of semaphorin 4DQ24294299
A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage BiologyQ26740406
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Early biomarkers of joint damage in rheumatoid and psoriatic arthritisQ28083506
The semaphorin genes encode a family of transmembrane and secreted growth cone guidance moleculesQ28118665
Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responsesQ28189775
Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activationQ28276903
The pathogenesis of rheumatoid arthritisQ29614957
Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin IIQ30498266
Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR CohortQ31038073
How to read radiographs according to the Sharp/van der Heijde method.Q33544536
The links between joint damage and disability in rheumatoid arthritisQ33867923
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritisQ34315745
Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritisQ34560081
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trialQ34651182
Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort studyQ35096891
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritisQ35555021
The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs).Q35610857
Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritisQ35617594
Radiological damage in patients with rheumatoid arthritis on sustained remissionQ35759974
Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritisQ35990362
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosusQ36246136
Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosisQ36317974
Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.Q37275562
Semaphorin 3A in Ankylosing Spondylitis.Q38665781
Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis.Q39936079
Osteoprotection by semaphorin 3A.Q41791623
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategiesQ41918491
Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse modelQ42371628
Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritisQ43500734
Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohortQ45078242
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritisQ46458365
RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory ArthritisQ46515547
The role of semaphorins in immune responses and autoimmune rheumatic diseasesQ47321853
The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient miceQ49157483
Semaphorin signaling in bone.Q50936117
The association between semaphorin 3A levels and gluten-free diet in patients with celiac disease.Q51002729
Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women.Q51318541
Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?Q51741939
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.Q51752129
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.Q53258549
The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.Q54407326
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.Q54528928
The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis.Q55405777
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcomeQ56974114
Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cellsQ74500047
Dickkopf-1 is a master regulator of joint remodelingQ79610564
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and functionQ82097189
Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA)Q83762288
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritisQ84142069
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expressionQ85062679
Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritisQ87401233
Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritisQ88361933
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P921main subjectmolecular biologyQ7202
rheumatoid arthritisQ187255
P304page(s)2318386
P577publication date2018-11-14
P1433published inDisease MarkersQ15756044
P1476titleCirculating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis
P478volume2018